Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x80px
Organisation › Details

4SC AG

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Such drugs are intended to provide patients with innovative treatment options that are more tolerable and efficacious than existing therapies and provide a better quality of life. 4SC’s pipeline is protected by a comprehensive portfolio of patents and currently comprises three key drug candidates in various stages of preclinical and clinical development: resminostat, 4SC-202 and 4SC-208. 4SC aims to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies and/or the eventual marketing and sales of approved drugs in select territories by 4SC itself. 4SC is headquartered in Planegg-Martinsried near Munich, Germany. The Company had 48 employees as of 31 December 2017 and is listed on the Prime Standard of the Frankfurt Stock Exchange (FSE Prime Standard: VSC; ISIN: DE000A14KL72). *

 

Period Start 1997-01-01 established_pre
  Group 4SC (Group)
  Predecessor 4SC GmbH
Product Industry drug screening (HTS)
Persons Person Loveridge, Jason (4SC 201609– CEO)
  Person 2 Doppler, Clemens (3i Germany 2007 Director Healthcare Team)
     
Region Region Martinsried
  Country Germany
  Street 22 Fraunhoferstr.
  City 82152 Martinsried
  Tel +49-89-700763-0
    Address record changed: 2018-07-24
     
Basic data Employees B: 11 to 50 (2017-12-31)
  Currency EUR
  Annual sales 4,197,000 (revenue, consolidated (2017) 2017-12-31)
  Profit -10,960,000 (2017-12-31)
  Cash 41,327,000 (2017-12-31)
     
    * Document for �About Section�: 4SC AG. (4/19/18). "Press Release: Phase II Study of 4SC’s Resminostat in Biliary Tract Cancer in Japan Is Initiated". Planegg-Martinsried.
     
   
Record changed: 2018-09-22

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px

More documents for 4SC (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x80px




» top